SCHEMBL22243115

SCHEMBL22243115

CC(C)(C)c1ccc2c(c1)c1ccccc1n2-c1ccc(C#N)cc1-c1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1-n1c2ccccc2c2cc(C(C)(C)C)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.38
CYP3A4 P08684 4/20 0.38
MEN1 O00255 3/20 0.38
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP2D6 P10635 3/20 0.38
TSHR P16473 3/20 0.38
LMNA P02545 3/20 0.38
CYP2C19 P33261 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP2C9 P11712 1/20 0.38
PTGER4 P35408 1/20 0.36
MAPK1 P28482 1/20 0.36
ABCG2 Q9UNQ0 10/20 0.35
ABCB1 P08183 3/20 0.35
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20793925 0.97 CYP1A2 (0.38) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL20793929 0.96 CYP1A2 (0.38) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL22243141 0.96 CYP1A2 (0.38) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL22243056 0.96 CYP1A2 (0.39) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL21364983 0.94 KIF11 (0.38) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL21364480 0.94 CYP1A2 (0.42) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL20794065 0.93 CYP1A2 (0.38) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL20794067 0.93 CYP1A2 (0.39) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL27015885 0.93 PTGER4 (0.36) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL21089854 0.92 CYP1A2 (0.38) CYP1A2CYP3A4MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11600783-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-03-07 US disclosed
US-20200235308-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235308-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OXER1, OR10J3, OXGR1 CYP1A2 784/4885CYP3A4 1180/4885MEN1 4157/4885
US-11600783-B2 Organic molecules for use in optoelectronic devices OR10J3, OR51E2, ALDH1A2 CYP1A2 444/4885CYP3A4 910/4885MEN1 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.